Stereotaxis Inc Share Price OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
05-13 | Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Stereotaxis to Buy Access Point Technologies | MT |
Sales 2024 * | 29.5M 2.34B | Sales 2025 * | 44.25M 3.51B | Capitalization | 172M 13.63B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.51B | Net income 2025 * | -16M -1.27B | EV / Sales 2024 * | 5.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-11.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 28/09/16 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 31/12/02 |
Laura Garth
LAW | General Counsel | - | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 30/04/05 |
Chief Executive Officer | 57 | 28/09/16 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 02/02/17 |
1st Jan change | Capi. | |
---|---|---|
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |